Compare FuelCell Energy Inc (FCEL) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FuelCell Energy Inc vs Organon & Co. Common Stock — how do they compare? FuelCell Energy Inc trades at $13.83 (market cap $1.24B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Organon & Co. Common Stock is far larger — about 2.9× FuelCell Energy Inc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold FuelCell Energy Inc for 48 Days and Organon & Co. Common Stock for 0 Days on average.
| FCEL | OGN | |
|---|---|---|
Market Cap | $1.24B | $3.62B |
Volume | 7,483,477 | 2,892,999 |
Sector | Industrials | Health |
52-Week High | $36.01 | $13.81 |
52-Week Low | $6.00 | $5.70 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | $818.79M | $11.04B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCEL trades at $15.495, down 5.35% today, with a bearish technical signal and mixed analyst ratings. The company shows persistent losses, with a net income margin of -113.6% in 2025, though revenue grew to $158.16M. Recent news highlights a securities class action lawsuit and a brief stock rally, reflecting high volatility and investor uncertainty amid ongoing financial challenges.
The outlook remains cautious due to sustained unprofitability and legal risks, but analyst consensus targets $21.57 suggest potential upside if execution improves. Key risks include cash burn, competitive pressures, and the outcome of litigation, requiring careful risk assessment for investors considering exposure to this speculative energy stock.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
